Sonova (OTCMKTS:SONVY) Hits New 1-Year Low - Should You Sell?

Key Points

• 52-week low: Sonova (SONVY) dropped to a new one-year low of $43.51 (last $43.57) on Monday, trading about 1,633 shares and well below its 50-day ($52.03) and 200-day ($53.21) moving averages.
• Analyst sentiment is mixed but leans positive: Two analysts rate the stock Strong Buy, one Buy, four Hold and one Sell, giving a consensus rating of "Moderate Buy".
• Company fundamentals: Sonova, a Switzerland-based hearing-care maker (brands include Phonak and Unitron), shows modest liquidity and leverage with a current ratio of 1.24, quick ratio of 0.91 and debt-to-equity of 0.51.

Sonova Holding (OTCMKTS:SONVY - Get Free Report)'s stock price reached a new 52-week low during trading on Monday . The company traded as low as $43.51 and last traded at $43.57, with a volume of 1633 shares trading hands. The stock had previously closed at $44.79.

Wall Street Analysts Forecast Growth

SONVY has been the subject of several recent analyst reports. BNP Paribas Exane raised shares of Sonova from a "strong sell" rating to a "strong-buy" rating in a report on Tuesday, March 10th. Zacks Research raised shares of Sonova from a "strong sell" rating to a "hold" rating in a research report on Monday, February 9th. Finally, Jefferies Financial Group cut shares of Sonova from a "hold" rating to a "moderate sell" rating in a report on Wednesday, March 18th. Two research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy".

Sonova Price Performance

The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51. The stock's 50-day moving average price is $52.03 and its 200 day moving average price is $53.21.

Sonova Company Profile

Sonova AG OTCMKTS: SONVY is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.